Context.-Each laboratory should have criteria for manual smear review that limit workload without affecting patient care. The International Consensus Group for Hematology Review established guidelines for action after automated blood cell analysis in 2005.
T he complete blood count (CBC) with leukocyte differential counts is one of the most frequently requested hematologic tests in medical laboratories. 1, 2 Despite the great precision, high accuracy, and expandability of automated hematologic analyzers, manual slide review (MSR) is still necessary to identify some morphologic abnormalities that may be relatively unremarkable in automated methods. 3 Each laboratory has its own criteria about when to perform manual smear review following automated blood count analysis. The laboratory productivity of CBC is inversely related to the number of manual differential count review rates; in addition, the rate of MSR is variable in each institution. 4 The commission on laboratory accreditation of the College of American Pathologists (CAP) requires each laboratory to have criteria for blood smear review and keep evidence of such reviews. 1 Siriraj Hospital is a tertiary university hospital located in Bangkok, Thailand. The hospital has a capacity of about 2200 beds and more than 1 million outpatient visits per year. The clinical pathology laboratory has 2 types of hematology analyzers: 2 Sysmex XE-5000 analyzers (Sysmex, Kobe, Japan), and 1 Coulter LH750 analyzer (Beckman Coulter Inc, Brea, California), which can produce 900 to 1300 CBC samples per day. The clinical pathology laboratory received specimens from inpatients and outpatients from all departments except the hematology clinic in Siriraj Hospital. The average analytic turnaround time is about 30 minutes and the MSR rate was approximately 22%.
Our laboratory used the list of criteria based on that of Gulati et al 5 and modified several parameters in accordance with the consensus between clinical pathologists and hematologists in the hospital. The sensitivity and specificity of these criteria had not been validated. In 2005, the International Consensus Group for Hematology Review established guidelines composed of 41 rules for action after automated analysis of a blood sample that had falsenegative and false-positive rates of 2.90% and 18.60%, respectively. 6 This study compared the efficiency of the series of criteria for first-time samples established by the International Consensus Group (consensus group criteria) and our laboratory criteria, and we optimized these criteria to improve efficiency.
MATERIALS AND METHODS

Study Samples
The study was performed in the clinical pathology laboratory of Siriraj Hospital, Mahidol University, in Thailand and was approved by the institutional review board. The samples were collected from daily workload, including outpatient and inpatient populations, from May 2010 to June 2010. All samples were first-time samples and collected consecutively.
The Automated Analyzers
Automated CBC and white blood cell (WBC) differential counts were performed with Coulter LH750 and Sysmex XE-5000 hematology analyzers. Reticulocyte counts were performed in several samples upon clinician request with Sysmex XE-5000 analyzers.
Manual Slide Review
Blood films were prepared by using a Sysmex SP-1000i automated hematology slide preparation unit. If blood volume was low, the blood films were smeared manually and then stained with the SP-1000i unit. Each blood film was examined independently by 2 experienced technicians who were not aware of the automated results. The technicians performed either manual scans (a cursory examination for a specific purpose such as to verify platelet [PLT] count or red blood cell [RBC] morphology) or manual leukocyte differential counts of peripheral smears according to the presence of WBC abnormalities or nucleated red blood cells (NRBCs). The positive smear result was defined as per the International Consensus Group criteria, which included RBC morphology at 2þ or greater, malaria, giant PLTs at moderate or greater, PLT clumps at greater than rare/occasional, Döhle bodies/ toxic granulation/vacuoles at moderate or greater, blasts at 1 or greater, metamyelocytes at greater than 2, myelocytes/promyelocytes at 1 or greater, atypical lymphocytes at greater than 5, NRBCs at 1 or greater, or plasma cell at 1 or greater. 6 All positive smear results and discrepant results between 2 technicians were reviewed by 2 laboratory physicians.
Statistical Analysis
Statistical analysis was performed with SPSS version 13.0 (SPSS Inc, Chicago, Illinois) and Excel software (Microsoft, Redmond, Washington). If a rule was triggered and the smear result was positive, the sample was graded as a ''true positive.'' If a rule was triggered and the smear did not have any positive findings, the sample was graded as a ''false positive.'' If a rule was not triggered and the smear result was negative, the sample was graded as a ''true negative.'' If a rule was not triggered but the smear contained a positive finding, the sample was graded as a ''false negative.'' v 2 and Fisher exact tests were used to compare the efficiency, falsepositive rate, false-negative rate, and review rate between different sets of criteria. A P value of .05 was considered statistically significant.
Efficiency is the ability of a test to correctly classify the true outcome, that is, the true-positive and true-negative results. Efficiency can be calculated as follows 7 
:
Efficiency ¼ (True Positives þ True Negatives)/All Cases.
Study Design
Optimization Set.-First, 2114 samples were used to compare the efficiency, false-negative rate, and review rate between the consensus group criteria and our laboratory criteria. We adjusted and selected the threshold of each parameter to achieve the highest efficiency. We accepted a false-negative rate of less than 5%, as recommended by the consensus group, and accepted a manual review rate of less than 30%, according to our capacity for smear review and the average review rate of the CAP survey. 4 Validation Set.-We applied the optimized group of criteria to a separate set of 891 samples. The efficiency and smear review rates of validation set were calculated. The false-positive and falsenegative cases were enumerated and clarified.
Additional Positive-Smear Cases.-We collected additional positive-smear samples, including 12 cases of confirmed thalassemia, 12 cases with atypical lymphocytes of more than 5%, and 12 cases with blasts of more than 1%. We tested the optimized criteria to determine whether they could detect the case.
RESULTS
Analysis of Smear Review Findings
A total of 2114 samples were collected from 825 males and 1289 females (mean age, 44 years; age range, 0-97 years). Only 200 samples came from pediatric patients (younger than 12 years). Samples were collected from 1840 outpatients (87.04%) and 274 inpatients (12.96%), and 1752 samples (82.88%) were analyzed by Sysmex XE-5000 analyzers.
From 2114 samples used in optimizing the smear review criteria, 368 (17.40%) had positive smear results according to the definition of the International Consensus Group. Among the positive samples, 230 (62.50%) had RBC abnormalities, 15 (4.08%) had WBC abnormalities, 67 (18.21%) had PLT abnormalities, 34 (9.24%) had both RBC and PLT abnormalities, 17 (4.62%) had RBC and WBC abnormalities, 3 (0.82%) had both WBC and PLT abnormalities, and 2 (0.54%) had RBC, WBC, and PLT abnormalities. The 3 most common findings of abnormal RBC morphology were microcytic RBC (215 occurrences), anisocytosis (85 occurrences), and hypochromic RBC (70 occurrences). For abnormal WBCs, the 3 most common findings were atypical lymphocytes (18 occurrences), blasts (9 occurrences), and myelocytes (6 occurrences). Platelet clumps (84 occurrences) were found more often than giant PLTs (34 occurrences). An automated CBC and WBC differential count analysis was performed on all 2114 samples; an automated reticulocyte count was performed on 58 samples upon clinician request.
Comparison of the Performance Between the Consensus Group Criteria and Laboratory Criteria
The criteria from the consensus group and our laboratory were different in several parameters (Table 1) . We used a total of 2114 samples to compare the efficiency, falsenegative rate, and review rate between both criteria. The efficiency was 83.63% in the consensus group criteria and 78.86% in the laboratory criteria (P , .001). The falsenegative rate was 2.22% with the consensus group criteria and 8.09% with the laboratory criteria (P , .001). The review rate was 29.33% with the consensus group criteria and 22.37% with the laboratory criteria (P , .001).
Optimized Criteria
We used both criteria as guidelines to adjust the threshold of each parameter to establish optimized criteria with better efficiency. From a total of 23 rules, 5 rules were related to CBC parameters, including hemoglobin, mean corpuscular volume (MCV), red cell distribution width (RDW), WBCs, and PLT count; 6 rules were related to the differential parameters for WBCs, including no or incomplete differential and absolute counts for 5 WBC types; 1 rule related to reticulocytes; and 11 rules related to suspect flags such as NRBC, blast, RBC fragment, and PLT clumps ( Table 2) . We did not include neonatal specimens in the criteria because most neonatal samples (75 of 77 samples) were triggered by the optimized criteria. One sample not triggered was the negative-smear sample; another was the positive smear because of the presence of polychromasia, PLT clumps, and giant PLTs, with a normal PLT count (PLTs, 330 3 10 3 /lL). Currently, our laboratory does not use an automated method to enumerate NRBCs, so our optimized criteria did not contain absolute NRBC counts.
Validation of the Optimized Criteria
After we obtained all of the rules for the optimized criteria, we validated them with the previous set of samples (n ¼ 2114). Compared to the consensus group criteria and the laboratory criteria, the efficiency was improved (P ¼ .001 when compared to the consensus group criteria and P , .001 when compared to the laboratory criteria). The false-negative rate in the optimized criteria slightly increased when compared to the consensus group criteria (P ¼ .15), but decreased when compared to the laboratory criteria (P , .001). The review rate declined in the optimized criteria when compared to the consensus group criteria (P , .001) but increased slightly when compared to the laboratory criteria (P ¼ .15, Table 3 ).
In the optimized criteria, we used a stricter threshold for MCV, low WBC counts, absolute neutrophil counts, and reticulocyte counts, leading to a reduction in peripheral smear reviews. Altering the threshold increased the falsenegative rate only in the low MCV rule; in contrast, the threshold from the optimized criteria significantly reduced the false-positive rate in the low MCV, low WBC counts, and high neutrophil counts rules. We used a lower cutoff value for high PLT counts, which caused 16 more cases to be reviewed. However, the false-positive and false-negative rates for the high PLT rule in the optimized criteria and the consensus group criteria were not significantly different (Table 4) . When we separated samples into inpatient and outpatient sources, the false-negative rates from both inpatients (3.65%) and outpatients (2.88%) were not different when compared with total samples (2.98%, P ¼ .68 and .93, respectively). However, the false-positive rate was very high in the inpatient group (21.90%) as compared to total samples (9.89%, P , .001), while that rate in the outpatient group was 8.10% (P ¼ .06) when compared with the total samples. The smear review rate in inpatient samples, outpatient samples, and total samples was 51.09%, 20.33%, and 24.31%, respectively.
We repeated validation of the optimized criteria by using another separate set of samples (n ¼ 891). In the validation set, the false-negative rate was only 1.12%, which was less than the optimization set (P ¼ .004); the review rate and efficiency were 25.25% and 87.32%, respectively, which were similar to the optimization sample set (P ¼ .62, P ¼ .94, respectively).
False-Negative and False-Positive Analysis
We conducted false-negative analysis of 3 sets of criteria, and we found that PLT morphology was the most frequent false-negative finding in the consensus group-suggested criteria and the optimized criteria. In laboratory criteria, the most frequent false-negative finding was RBC morphology because this set of criteria did not include the low MCV and RDW rule. The most common RBC morphology (grade 2þ or greater) missed was microcytic RBC (107 occurrences), followed by anisocytosis (21 occurrences), hypochromic RBC (21 occurrences), and target cell (21 occurrences). False-negative results that had abnormal PLT morphology from the consensus group criteria, laboratory criteria, and optimized criteria had PLT counts of 107 3 10 (Table 5) .
After false-positive analysis, the data indicated that the MCV criteria (117 occurrences) caused the most falsepositive smear reviews in the consensus group criteria. One hundred and twelve cases were triggered by MCV less than 75 fL, whereas 5 cases were triggered by MCV greater than 105 fL. Lymphocyte count greater than 4000/lL or .70% and hemoglobin levels lower than 10 g/dL caused the most false-positive smear reviews in the laboratory criteria. Immature granulocyte, blast, and NRBC flags caused the most false-positive results with the optimized criteria (Table  6 ). 
Additional Positive-Smear Cases
In all 12 thalassemic cases, 12 samples with more than 5% atypical lymphocytes (range, 6%-35.20%; mean 6 SD, 14.39 6 8.28%) and 12 samples with more than 1% blasts (range, 5%-73.20%; mean 6 SD, 22.74 6 21.49%) were triggered by our optimized criteria. The 3 most common criteria were triggered in each group of samples as follows: in thalassemic cases, 12 of 12 (100%) were triggered by RDW criteria, 11 of 12 (91.67%) were triggered by the NRBC flag, and 8 of 12 (66.67%) were triggered by PLT counts greater than 600 3 10 3 /lL. In samples with atypical lymphocytes, 11 of 12 (91.67%) were triggered by PLT counts less than 100 3 10 3 /lL, 10 of 12 (83.33%) were triggered by atypical lymphocyte flags, and 9 of 12 (75%) were triggered by blast flags (abnormal lymphocytes/ lymphoblast flags). In samples with blasts, 11 of 12 (91.67%) were triggered by blast flags, 11 of 12 (91.67%) were triggered by PLT counts less than 100 3 10 3 /lL, and 8 of 12 (66.67%) were triggered by atypical lymphocyte flags.
COMMENT
The International Consensus Group for Hematology Review suggests that each laboratory adopting the criteria for action, following automated blood cell analysis, validate its operation before implementation. 6 No guidelines can be used universally and also be economically feasible. 8 Our laboratory had been using the set of criteria established by our expert opinion consensus, but it had not been validated.
In this study, first we compared the consensus group criteria with our current laboratory criteria. The consensus group criteria had higher efficiency and a lower falsenegative rate; however, the review rate of 29.33% was significantly higher than that in the laboratory criteria. After we optimized the criteria, the efficiency was improved, and the review rate of 24.31% was lower than the review rate from the consensus group criteria but higher than the rate from the laboratory criteria.
The manual smear review is labor-intensive, timeconsuming, and may not be necessary. In the CAP QProbes Program study with 263 participating hospitals and laboratories, the rates of MSR varied among participants, with a median of 26.70%. The manual scan rate increased with a greater number of hospital beds, but the manual leukocyte differential count rate decreased. That study illustrated that reducing the review rate was directly related to the efficiency of generating CBC results. 4 Our optimized criteria increased the rate of MSR insignificantly, but the significantly improved efficiency made the criteria satisfactory.
Our optimized criteria were the same as those of the consensus group criteria for low hemoglobin values, RDW, high WBC counts, low PLT, eosinophil counts, basophil counts, no or incomplete differential counts, and the presence of suspect flags. However, after we selected the cutoff values that achieved the highest efficiency, our optimized criteria were different from those of the consensus group in several parameters.
The stricter threshold we used in the optimized criteria reduced the peripheral smear review rate without increasing the false-negative rate in high MCV, low WBC count, absolute neutrophil count, and reticulocyte criteria. In the low MCV rule, the false-negative rate increased after we adjusted the threshold; however, in patients with microcytosis, the blood smear review may not be useful to discriminate between iron-deficiency anemia, thalassemia minor, and anemia of chronic disease. 9 We did not specify criteria for different age and sex, so we selected a single cutoff value for high hemoglobin values, high lymphocyte counts, and high monocyte counts. For high PLT counts, we used a lower cutoff value, which slightly increased the smear review rate.
Our samples were first-time samples, so most of them were collected from outpatient sources. The false-negative rate was not significantly different between inpatient, outpatient, and total samples. Therefore, optimized criteria can be used in both inpatient and outpatient samples. The disadvantage was that the high false-positive rate in inpatient samples would lead to a high smear review rate. The false-negative rate in the optimized criteria (2.98%) was insignificantly higher than that from the consensus group criteria (2.22%) but was significantly decreased when compared with the laboratory criteria (8.09%). According to the International Consensus Group, the false-negative rate should be less than 5% to ensure patient safety. 6 When validating the optimized criteria with another set of samples, the efficiency and the review rate in the validation set were nearly similar to the optimization set. The falsenegative rate was slightly lower in the validation set. As a result, our optimized criteria were reproducible.
The most common cause of false-negatives when we used the laboratory criteria was RBC morphology. We did not include the low MCV and high RDW in our laboratory criteria because there are many patients with hemoglobinopathies in Thailand, 10 which may cause a very high review rate. Clinicians can use information from hemoglobin, MCV, and RDW from automated results to further investigate for final diagnosis. However, when we included low MCV and high RDW in the optimized criteria, as well as reduced the threshold of hemoglobin, the review rate did not increase significantly, while the false-negative rate decreased significantly. The reporting of RBC morphology was still useful for clinicians, 11 so we decided to include these 2 parameters in our optimized criteria.
For false-negatives caused by abnormal PLT morphology, only a few cases had PLT counts less than 150 3 10 3 /lL, which was defined as thrombocytopenia.
12 However, patients with PLT counts between 100 3 10 /lL would decrease concerns about mild physiologic thrombocytopenia during pregnancy. 13 For these reasons, physicians may examine patients with thrombocytopenia when PLT counts are less than 100 3 10 3 /lL. Hence, the presence of abnormal PLT morphology in these samples, which had PLT counts of 100 3 10 3 /lL to 150 310 3 /lL, would be acceptable. Most of the neonatal samples were triggered by the optimized criteria. One positive case with the presence of polychromasia, PLT clumps, and giant PLTs was missed by the criteria. However, polychromasia, macrocytic normochromic cells, and a few NRBCs can be found in normal newborn infant blood films. 14 The presence of PLT clumps and giant PLTs in this case, which had a normal PLT count, was also not clinically significant.
No cases of blasts would have been missed by the consensus group criteria, laboratory criteria, or optimized criteria. However, there were only cases with blasts in 2114 cases, so we selected 12 more cases with the presence of blasts to check our criteria. Still, no cases with blasts were missed by the optimized criteria, although the blast flag was only detected in 11 of 12 cases. One additional case was triggered by low WBC counts, a low neutrophil count, and low PLT count criteria.
Since lymphocyte findings were difficult to classify, either within the reference range or as atypical lymphocytes, and were varied among individual observers, 15 we thought that occasionally missing cases with increased atypical lymphocytes was acceptable. However, only 3 in 18 cases of increased atypical lymphocytes were missed. In addition, in 12 additional atypical lymphocyte cases, all cases were triggered by our optimized criteria. Ten of 12 cases were triggered by atypical lymphocyte flag and 11 of 12 cases were triggered by PLT counts lower than 100 3 10 3 /lL because most of these cases had Dengue viral infections, which is prevalent in Thailand. 16 The causes of false-positive cases in our current laboratory criteria mostly come from the lymphocyte count criteria and hemoglobin levels lower than 10 g/dL. After we adjusted the threshold of both criteria, the false-positive rate improved in our optimized criteria. Also, the most common cause of false-positives in the consensus group criteria was MCV criteria, especially low MCV (,75 fL). Thailand has many people with the thalassemia trait who may have slightly low hemoglobin levels and low MCV but whose blood smear would be slightly abnormal (less than grade 2þ) and give rise to false-positive results.
There are a number of limitations to the current study: (1) There were small samples collected from patients younger than 12 years, so we did not define the age-specific criteria for absolute lymphocyte and monocyte counts. On the other hand, non-age-specific criteria will be easy to use in routine clinical practice, (2) These data were generated from a single geographic area with a high prevalence of thalassemia and Dengue fever. Because of these regional factors, the precise cutoffs and rules that proved most efficient in our laboratory may not be the optimal rules to apply in laboratories working in other regions of the globe, (3) Samples were collected consecutively in a period of 2 months, so some uncommon positive findings were not observed during the study, such as malaria, RBC autoagglutination, and rouleaux formation. As a result, the efficacy of the optimized criteria in these positive findings could not be assured.
In summary, we compared 2 sets of criteria, the International Consensus Group for Hematology Review criteria and our laboratory criteria. The consensus group criteria had higher efficiency with a higher review rate. From these 2 criteria, we adjusted each parameter to improve overall efficiency and generate optimized criteria. All laboratories should have their own criteria for smear review. Criteria can be based on the consensus group criteria but should be verified before adoption or optimized to be suitable for different requirements.
